4//SEC Filing
Dreyer Scott 4
Accession 0001062993-25-002179
CIK 0001267565other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:10 PM ET
Size
9.9 KB
Accession
0001062993-25-002179
Insider Transaction Report
Form 4
Dreyer Scott
EVP & Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2025-02-10$30.52/sh−21,670$661,368→ 147,706 total - Award
Common Stock
2025-02-10+45,016→ 150,918 total - Award
Common Stock
2025-02-10+26,411→ 177,329 total - Tax Payment
Common Stock
2025-02-10$30.52/sh−7,953$242,726→ 169,376 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 26,411 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
- [F3]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
- [F4]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001746251
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:10 PM ET
- Size
- 9.9 KB